<DOC>
	<DOCNO>NCT01608178</DOCNO>
	<brief_summary>Background : - Succinic semialdehyde dehydrogenase ( SSADH ) deficiency rare genetic disease result change certain brain chemical . These chemical may affect brain excitability , likely nerve cell turn . Changes brain excitability may help explain symptoms disease , include learn memory problem , seizure , poor balance . A supplement call taurine may help people SSADH deficiency work brain chemical GABA . GABA help regulate brain activity . Researchers want see taurine help people SSADH deficiency . Objectives : - To learn taurine affect brain people SSADH deficiency . Eligibility : - Individuals least 12 year age SSADH deficiency . Design : - Participants screen physical exam medical history . They provide blood urine sample . They also take taurine supplement part protocol . - Participants two set study test . One set give participant take taurine . The second give take . Each test session take 2 day complete . - Half participant `` taurine '' test start taurine supplement . The half start take taurine first , `` taurine '' testing , `` taurine '' test 3 month stop taurine . Participants may decide order test do . - Participants follow test two test visit : - Paper pencil test learn memory . - Transcranial magnetic stimulation study excitability nerve cell . - Imaging study show GABA receptor brain measure activity . - Electroencephalogram measure brain wave . - Lumbar puncture collect spinal fluid . - Participants monitor regular study visit receive taurine supplement treatment .</brief_summary>
	<brief_title>Taurine Therapy SSADH Deficiency</brief_title>
	<detailed_description>Objective : To study physiologic effect taurine therapy patient succinic semialdehyde Dehydrogenase ( SSADH ) deficiency . Study Population : Eighteen child adult SSADH deficiency receive taurine . Design : This small open label trial evaluate effect taurine treatment key SSADH biomarkers neurocognitive performance . Study evaluation include neurological neuropsychological examination , positron emission tomography ( PET ) 11C-flumazenil ( FMZ ) , ( optional age 18 ) , magnetic resonance spectroscopy ( MRS ) ( optional ) cerebrospinal fluid ( CSF ) collection ( optional ) measure gamma-aminobutyric acid ( GABA ) level , transcranial magnetic stimulation ( TMS ) measure cortical excitation inhibition , patient give taurine SSADH deficiency . The evaluation perform twice , therapy .</detailed_description>
	<criteria>INCLUSION CRITERIA : Persistent 4hydroxybutyric aciduria ( gammahydroxybutyric aciduria ) . Documented succinic semialdehyde dehydrogenase enzyme deficiency . Patients least 12 year old . Be enrol taurine study CNMC . EXCLUSION CRITERIA : Pregnancy lactation . Patients history significant medical disorder . Patients require treatment drug know affect GABAergic system , include vigabatrin , barbiturate , benzodiazepine . Hearing loss . The effect TMS hearing fully know . Patients screen Audiometer . Abnormal platelets coagulation study suggest increase risk lumbar puncture TMS Exclusions MRI MRS : pacemaker implant electrical device , brain stimulators , type dental implant , aneurysm clip ( metal clip wall large artery ) , metallic prosthesis ( include metal pin rod , heart valve , cochlear implant ) , permanent eyeliner , implanted delivery pump , shrapnel fragment , welder metal worker . Exclusions TMS : people implant medical device pacemaker , implanted pump , stimulators , cochlear implant people metal object inside eye skull .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 16, 2013</verification_date>
	<keyword>Pediatric Neurotransmitter Disorders</keyword>
	<keyword>Succinic Semialdehyde Dehydrogenase</keyword>
	<keyword>GABA</keyword>
	<keyword>Epilepsy</keyword>
</DOC>